当前位置: X-MOL 学术Nat. Rev. Drug. Disc. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
FDA OKs first in vitro route to expanded approval
Nature Reviews Drug Discovery ( IF 122.7 ) Pub Date : 2017-09-01 , DOI: 10.1038/nrd.2017.140
Katie Kingwell

In vitro data can be used to accelerate the approval of drugs that target specific disease-causing mutations for additional subpopulations of patients with rare diseases such as cystic fibrosis.

中文翻译:

FDA OKS首先在体外路线扩大审批

体外数据可用于加速针对特定疾病致突变的药物的批准,这些药物可用于患有罕见疾病(如囊性纤维化)的患者的其他亚群。
更新日期:2017-09-04
down
wechat
bug